检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]哈尔滨医科大学生理学教研室,黑龙江哈尔滨150086 [2]天津中医药大学针灸学院,天津300193
出 处:《中国医药导报》2014年第24期33-35,共3页China Medical Herald
基 金:黑龙江省卫生厅科技计划项目(编号2010-178)
摘 要:目的:探讨成功建立大鼠局灶性脑缺血模型的有效方法及影响因素。方法将大鼠分为250-300 g和350-400 g两个体重组。为观察禁食对造模的影响,250-300 g体重组又分为对照组(n=10)和禁食组(n=10);为观察栓线直径对造模的影响,350-400 g体重组又分为细栓线组(n=10)和粗栓线组(n=10)。栓线经颈总动脉、颈内动脉进入大脑中动脉的起始部位阻断大脑中动脉的血流。术后通过神经功能缺损评分和氯化三苯基四氮唑(TTC)染色对该模型进行评价。结果在250-300 g体重组,造模成功率高,禁食组死亡率(11.1%)明显低于对照组(62.5%)(P〈0.05);在350-400 g体重组,死亡率低,粗栓线组造模成功率(80%)明显高于细栓线组(20%)(P〈0.05)。结论术前禁食可降低动物死亡率,根据大鼠体重选择相应直径的栓线可提高造模的成功率。Objective To investigate the method and influence factors of establishing focal ischemia model of rat successfully. Methods Rats were divided into two groups, 250-300 g group and 350-400 g group. In order to observe the influence of fasting on the model, 250-300 g group was subdivided into two groups, control group (n=10) and fasting group (n=10). In order to observe the influence of the bolt line diameter on the model, 350-400 g group was sub-divid-ed into two groups, thin bolt line group (n=10) and bold bolt line group (n=10). The bolt line entered from a cut of the common carotid artery and moved in the intracranial internal carotid artery and at last reached to the starting positions of middle cerebral artery to block blood flow. The nerve function defect score and TTC staining were used to evaluate the model. Results In the 250-300 g group, the success rate was high and mortality of the fasting group (11.1%) was lower than the control group (62.5%) (P〈0.05). In the 350-400 g group, mortality was low and the success rate of the bold bolt line group (80%) was higher than the thin bolt line group (20%) (P〈 0.05). Conclusion Fasting can reduce animal mortality. Selecting the bolt line according to the weight of rats can increase success rate.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15